US gives full approval for antiviral Remdesivir drug to treat the COVID-19 patients
Shortpedia
Content Team
Image Credit: Shortpedia
US regulators have given full approval for the antiviral drug remdesivir to treat the Covid-19 patients in hospitals. The US Food and Drug Administration (FDA) said Veklury, the drug's brand name, cut the recovery time on average by five days during clinical trials. "Veklury is the first treatment for COVID-19 to receive FDA approval," the FDA said in a statement, the BBC reported on Friday.
